Browse diseases

…y treatment for articular and extra-articular manifestations of rheumatoid arthritis. These include conventional synthetic DMARDs such as Methotrexa…

…h STOP-BANG <3.Conclusion In this female-predominant, difficult asthma cohort, STOP-BANG ≥3 showed modest sensitivity and limited spec…

…ndard asthma treatment and exposure control. Isocyanate-related OA was associated with persistent symptoms despite cessation of ex…

…Introduction Lung cancer and cardiovascular disease are leading causes of death in indiv…

…s of accuracy may not be adequate for clinical use in the acute stroke setting. The OCS may be useful for identifying patients with do…

…s like head and neck lung cancers, hepatocellular carcinoma and renal cell carcinoma. We have some encouraging data from our centre, as well as from…

…xhibited comparable HCC risk (HR=1.76; 95% CI 0.84 to 3.71) and extrahepatic cancer risk (HR=1.14; 95% CI 0.88 to 1.48), but reduced CVD risk (HR=0…

…opulation attributable fractions for PM1-related mortality from COPD, chronic bronchitis, emphysema and AECOPD were 8.86%, 8.84%, 8.…

…lymphoma, from 1999 onwards they started treating patients with rheumatoid arthritis with this B-cell depleting agent. Its effectiveness was obvious…

… COVID-19 and other illnesses, especially in unpaid work. Acute COVID-19, despite being associated with high losses at low quantiles, do…

…Objective Lymph node silicosis may be diagnosed incidentally during investigations of lung and…

…sis, 25 patients (5.2%) had F2 fibrosis, 33 patients (6.4%) had F3 fibrosis, and 46 patients (9.6%) had F4 fibrosis. Of those patients with…